Business Description
KYUNGNAM PHARM Co Ltd
ISIN : KR7053950002
Compare
Compare
Traded in other countries / regions
053950.Korea Index Membership
KOSDAQ Composite Index IPO Date
2001-11-06Description
KYUNGNAM PHARM Co Ltd manufactures and markets medicines and health-aids foods.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.83 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.44 | |||||
Debt-to-EBITDA | -3.07 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.47 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19 | |||||
3-Year EBITDA Growth Rate | -24.8 | |||||
3-Year FCF Growth Rate | 50.2 | |||||
3-Year Book Growth Rate | -8.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.99 | |||||
9-Day RSI | 38.56 | |||||
14-Day RSI | 39.55 | |||||
3-1 Month Momentum % | -6.33 | |||||
6-1 Month Momentum % | -12.22 | |||||
12-1 Month Momentum % | -30.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.76 | |||||
Days Inventory | 87.63 | |||||
Days Sales Outstanding | 81.9 | |||||
Days Payable | 33.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.7 | |||||
Shareholder Yield % | -8.74 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.56 | |||||
Operating Margin % | -9.06 | |||||
Net Margin % | -4.47 | |||||
FCF Margin % | 2.65 | |||||
ROE % | -3.63 | |||||
ROA % | -2.01 | |||||
ROIC % | -4.85 | |||||
3-Year ROIIC % | -16.91 | |||||
ROC (Joel Greenblatt) % | -30.43 | |||||
ROCE % | -15.66 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.41 | |||||
PB Ratio | 0.25 | |||||
Price-to-Tangible-Book | 0.26 | |||||
Price-to-Free-Cash-Flow | 10.19 | |||||
Price-to-Operating-Cash-Flow | 6.9 | |||||
EV-to-EBIT | -3.31 | |||||
EV-to-EBITDA | -4.09 | |||||
EV-to-Revenue | 0.76 | |||||
EV-to-FCF | 28.52 | |||||
Price-to-GF-Value | 0.53 | |||||
Price-to-Projected-FCF | 3.3 | |||||
Price-to-Median-PS-Value | 0.22 | |||||
Price-to-Net-Current-Asset-Value | 3.23 | |||||
Earnings Yield (Greenblatt) % | -30.11 | |||||
FCF Yield % | 4.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
KYUNGNAM PHARM Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 72,097.065 | ||
EPS (TTM) (â‚©) | -163.489 | ||
Beta | 0.02 | ||
3-Year Sharpe Ratio | -0.86 | ||
3-Year Sortino Ratio | -1.11 | ||
Volatility % | 29.55 | ||
14-Day RSI | 39.55 | ||
14-Day ATR (â‚©) | 20.224466 | ||
20-Day SMA (â‚©) | 670.7 | ||
12-1 Month Momentum % | -30.89 | ||
52-Week Range (â‚©) | 540 - 1399.938095 | ||
Shares Outstanding (Mil) | 70.59 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
KYUNGNAM PHARM Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
KYUNGNAM PHARM Co Ltd Stock Events
Event | Date | Price (â‚©) | ||
---|---|---|---|---|
No Event Data |
KYUNGNAM PHARM Co Ltd Frequently Asked Questions
What is KYUNGNAM PHARM Co Ltd(XKRX:053950)'s stock price today?
The current price of XKRX:053950 is â‚©665.00. The 52 week high of XKRX:053950 is â‚©1399.94 and 52 week low is â‚©540.00.
When is next earnings date of KYUNGNAM PHARM Co Ltd(XKRX:053950)?
The next earnings date of KYUNGNAM PHARM Co Ltd(XKRX:053950) is .
Does KYUNGNAM PHARM Co Ltd(XKRX:053950) pay dividends? If so, how much?
KYUNGNAM PHARM Co Ltd(XKRX:053950) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |